Evidence map›Paper›PMID 35136059›Full record

ArticleNature communications2022

Beta-cell specific Insr deletion promotes insulin hypersecretion and improves glucose tolerance prior to global insulin resistance.

Søs Skovsø, Evgeniy Panzhinskiy, Jelena Kolic, Haoning Howard Cen, Derek A Dionne, Xiao-Qing Dai, Rohit B Sharma, Lynda Elghazi, Cara E Ellis, Katharine Faulkner and 26 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors at 6 institutions in 2 countries.

Søs SkovsøDiabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
Evgeniy PanzhinskiyDiabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
Jelena KolicDiabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.ORCID http://orcid.org/0000-0003-4151-1280
Haoning Howard CenDiabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.ORCID http://orcid.org/0000-0001-8045-1335
Derek A DionneDiabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
Xiao-Qing DaiAlberta Diabetes Institute and Department of Pharmacology, University of Alberta, Edmonton, Canada.
Rohit B SharmaDivision of Endocrinology, Diabetes and Metabolism and the Weill Center for Metabolic Health, Weill Cornell Medicine, New York, NY, USA.
Lynda ElghaziDepartment of Ophthalmology and Visual Sciences, University of Michigan Kellogg Eye Center, Ann Arbor, MI, USA.
Cara E EllisDiabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
Katharine FaulknerDepartment of Mathematics, University of British Columbia, Vancouver, BC, Canada.
Stephanie A M MarcilDiabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
Peter OverbyDiabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
Nilou NoursadeghiDiabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
Daria HutchinsonDiabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
Xiaoke HuDiabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
Hong LiDiabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
Honey ModiDiabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
Jennifer S WildiDiabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
J Diego BotezelliDiabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
Hye Lim NohProgram in Molecular Medicine University of Massachusetts Medical School, Worcester, MA, USA.
Sujin SukProgram in Molecular Medicine University of Massachusetts Medical School, Worcester, MA, USA.
Brian GablaskiDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
Austin BautistaAlberta Diabetes Institute and Department of Pharmacology, University of Alberta, Edmonton, Canada.
Ryekjang KimAlberta Diabetes Institute and Department of Pharmacology, University of Alberta, Edmonton, Canada.
Corentin Cras-MéneurDepartment of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0001-8921-8927
Stephane FlibotteUBC Life Sciences Institute Bioinformatics Facility, University of British Columbia, Vancouver, BC, Canada.
Sunita SinhaUBC Sequencing and Bioinformatics Consortium, Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
Dan S LucianiBC Children's Hospital Research Institute, Department of Surgery, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Corey NislowUBC Sequencing and Bioinformatics Consortium, Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.ORCID http://orcid.org/0000-0002-4016-8874
Elizabeth J RideoutDiabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
Eric N CytrynbaumDepartment of Mathematics, University of British Columbia, Vancouver, BC, Canada.ORCID http://orcid.org/0000-0001-8789-1667
Jason K KimProgram in Molecular Medicine University of Massachusetts Medical School, Worcester, MA, USA.ORCID http://orcid.org/0000-0002-7185-042X
Ernesto Bernal-MizrachiDivision of Endocrinology, Diabetes and Metabolism, University of Miami Miller School of Medicine and Miami VA Health Care System, Miami, FL, USA.
Laura C AlonsoDivision of Endocrinology, Diabetes and Metabolism and the Weill Center for Metabolic Health, Weill Cornell Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0001-5056-8970
Patrick E MacDonaldAlberta Diabetes Institute and Department of Pharmacology, University of Alberta, Edmonton, Canada.
James D JohnsonDiabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada. James.d.johnson@ubc.ca.ORCID http://orcid.org/0000-0002-7523-9433
University of British Columbia · CAUniversity of Alberta · CAUniversity of Massachusetts Chan Medical School · USCornell University · USUniversity of Michigan · USUniversity of Miami Health System · US

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WILLIAM H HERMAN · 2013 to 2026
$24.3M
AKT/mTOR Signaling and Regulation of Cell Cycle in beta CellsR01DK073716 · NIDDK · WASHINGTON UNIVERSITY · PI BERNAL-MIZRACHI, ERNESTO · 2006 to 2022
$4.6M
UMass Mouse Metabolic Phenotyping Center - Metabolism CoreU2CDK093000 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KIM, JASON K · 2016 to 2021
$4.6M
UMass Mouse Metabolic Phenotyping CenterU24DK093000 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KIM, JASON K · 2011 to 2015
$2.1M
ATF6 and the Beta CellR01DK114686 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI ALONSO, LAURA C · 2017 to 2019
$1.5M
mTOR signaling and regulation of alpha-cell mass and functionI01BX002728 · VA · MIAMI VA HEALTH CARE SYSTEM · PI BERNAL-MIZRACHI, ERNESTO · 2016 to 2025
–
BLRD VA I01 BX002728NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK073716NIDDK NIH HHS R01 DK114686NIDDK NIH HHS U24 DK093000NIDDK NIH HHS U2C DK093000
6 · The paper itself

Abstract

Insulin receptor (Insr) protein is present at higher levels in pancreatic β-cells than in most other tissues, but the consequences of β-cell insulin resistance remain enigmatic. Here, we use an Ins1

Indexed as

AnimalsDatasets as TopicDiabetes Mellitus, Type 2Diet, High-FatDisease Models, AnimalFemaleGene Knock-In TechniquesGene Knockout TechniquesGlucoseHumansHyperinsulinismInsulinInsulin ResistanceInsulin-Secreting CellsMaleMiceGlucoseInsulinReceptor, Insulin

Identifiers

PMID35136059
PMCPMC8826929
OpenAlexW4220846615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.